Fifty-First ACBTSA Meeting (online)

August 26, 2020 - August 27, 2020

Agenda

August 26, 2020

TIMEAGENDA ITEMSPEAKER
Committee Business
12:30 p.m.Welcome and Swearing-in 

Admiral Brett P. Giroir, Assistant Secretary for Health

Jackie Frederick, MT (ASCP) SBB, MBA, Hon DB/DPH, Chair

12:40 p.m.Roll CallJames Berger, MS, MT (ASCP) SBB
12:45 p.m.Purpose of the Meeting

Jackie Frederick, MT (ASCP) SBB, MBA, Hon DB/DPH, Chair

Jay Menitove, MD

1:00 p.m.Introductory Presentation and Overview of the Public Health Emergencies; Clinical Perspective and Historical Perspective

Merlyn Sayers, MD, Blood Center and Clinical Perspective

Roger Dodd, PhD

Current Experience during the COVID-19 Pandemic
1:30 p.m.AABB Interorganizational Disaster Task Force ResponseBrian Gannon, Chairman, AABB Interorganizational Disaster Task Force and CEO, Gulf Coast Regional Blood Center
1:50 p.m.Experience of Hospitals and Transfusion ServicesClaudia Cohn, MD, CMO, AABB and Associate Professor of Laboratory Medicine and Pathology, University of Minnesota
2:20 p.m.Experience of Blood Centers: Donor Engagement, Blood Donors and Donation Process, and Public Awareness and CommunicationsMike Parejko, CEO, Mississippi Valley Regional Blood Center and President, America's Blood Centers
2:50 p.m.Afternoon Break 
3:15 p.m.Experience of Blood Centers: Blood Inventories, Supply Chain, CCP, and Financial Impact

Bill Block, CEO, Blood Centers of America

Chris Hrouda, President, Biomedical Services, American Red Cross 

David Green, President and CEO, Vitalant

4:15 p.m.Experience of FDA: Blood Products IndustryPeter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research, FDA
4:45 p.m.Manufacturer ExperienceDean Gregory, President, Global Commercial Operations for Transfusion Medicine and Cell Therapy, Fresenius Kabi
5:15 p.m.Adjournment 

August 27, 2020

TIMEAGENDA ITEMSPEAKER
Committee Business
8:30 a.m.Call to OrderJackie Fredrick, MT (ASCP) SBB, MBA, Hon DB/DPH
8:40 a.m.Roll CallJames Berger, MS, MT (ASCP) SBB
8:50 a.m.First Day Recap of the MeetingJay Menitove, MD
9:00 a.m.Government Data Collection Systems for Transfusion Medicine and Blood Operations

Steven A. Anderson, PhD, MPP, Director, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, FDA

Sridhar V. Basavaraju, MD, Director, Office of Blood, Organ, and Other Tissue Safety, Centers for Disease Control and Prevention

Simone Glynn MD, MSc, MPH, Chief, Blood Epidemiology and Clinical Therapeutics Branch, National Heart, Lung, and Blood Institute

Stakeholder Statements and Presentations
9:30 a.m.Patient PerspectiveNathan Schafer, APLUS
9:50 a.m.AABBDebra BenAvram, FASAE, CAE, CEO, AABB
10:10 a.m.America's Blood Centers

Kate FryMBA, CAE, CEO, America's Blood Centers

 
10:30 a.m.American Red Cross Chris Hrouda, President, Biomedical Services, American Red Cross 
10:50 a.m.Morning Break 
11:05 a.m.U.S. Department of DefenseColonel Audra L. Taylor, Division Chief,  Armed Services Blood Program, U.S. Department of Defense
11:25 a.m.Plasma Protein Therapeutics Association Amy Efantis, President and CEO, Plasma Protein Therapeutics Association 
11:45 a.m.Public Comment 
12:00 p.m.Lunch 
Considerations for the Future
1:00 p.m.Blood-based Therapies for Patient Treatment, CCP, and Other ImmunotherapiesMichael Joyner, MD, Mayo Clinic
1:30 p.m.Innovation in Blood Products for the Future, Responding to Public Health Emergencies John Holcomb, MD
2:00 p.m.Q&A

Michael Joyner, MD, Mayo Clinic

John Holcomb, MD

2:30 p.m.Afternoon Break 
Discussion, Questions, and Recommendations
2:45 p.m.Committee Discussion 
3:45 p.m.Formulation of Committee Findings and RecommendationsJay Menitove, MD
4:45 p.m.New Business and Next StepsJackie Frederick, MT (ASCP) SBB, MBA, Hon DB/DPH, Chair
5:00 p.m.AdjournmentJames Berger, MS, MT (ASCP) SBB

The fifty-first meeting of the Advisory Committee on Blood and Tissue Safety and Availability was held on August 26 and 27.

Meeting Summary - August 27

Meeting Summary - August 26

Federal Register Notice

View the Meeting Recording

View a recording of the meeting.

 

Content last reviewed